Cite

HARVARD Citation

    Cernuda‐Morollón, E. et al. (2014). CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine. Headache. 54 (6), pp. 987-995. [Online]. 
  
Back to record